Once-Weekly Treatment Approved for Achondroplasia in Kids

By News Health
2 hours Ago

(MedPage Today) — The FDA approved navepegritide (Yuviwel) for children ages 2 and older with achondroplasia, the most common form of dwarfism, developer Ascendis Pharma announced on Friday.
The prodrug of C-type natriuretic peptide (CNP) is…

Source link : https://www.medpagetoday.com/endocrinology/growthdisorders/120113

Author :

Publish date : 2026-03-02 19:09:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Problems Arise at the Intersection of Alcohol and GLP-1s

The Doctors Are Not Alright

Can Lithium Protect the Aging Brain?

Yoga for Kids? Use of Alternative Medicine Has Grown Among Younger Americans

Electrolyte Supplements Are Everywhere. Who Benefits From Them and When?

NHS Boosts Bone Scanning With 20 New DEXA Units